Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
With a market cap of 85.21B, Regeneron(REGN) trades at $827.72. The stock has a price-to-earnings ratio of 20.46 and currently yields dividends of 0.45%.
As of 2026-09-05, Regeneron(REGN) stock has fluctuated between $825.83 and $841.53. The current price stands at $827.72, placing the stock +0.2% above today's low and -1.6% off the high.
Regeneron(REGN) shares are trading with a volume of 535.17K, against a daily average of 640.21K.
In the last year, Regeneron(REGN) shares hit a 52-week high of $859.34 and a 52-week low of $541.00.
In the last year, Regeneron(REGN) shares hit a 52-week high of $859.34 and a 52-week low of $541.00.
REGN News
...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. The Phase 1/2 study A Phase 1/2, Open-label Study Evaluating the Safety,...
Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic os...
Analyst ratings
62%
of 29 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.